• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35.
Citation: NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35.

NMR Analysis of Bromocriptine Mesilate Tenoxicam

More Information
  • One and two dimentional NMR spectra of tenoxicam were measured and meticulously analysed. Therefore, all the proton and carbon signals in the spectra were properly assigned, and all the proton coupling constants calculated.
  • Related Articles

    [1]ZHOU Hongyou, GAO Xiangdong, YAO Wenbing, TIAN Hong. Screening of adjuvant for PD-L1 vaccine based on nitrated T cell epitope[J]. Journal of China Pharmaceutical University, 2024, 55(3): 397-403. DOI: 10.11665/j.issn.1000-5048.2023032801
    [2]WANG Zhijie, LIAO Xiaotong, GUO Xia, CHEN Jianjun. New strategies for targeting PD-1/PD-L1: degraders, bifunctional molecules and covalent inhibitors[J]. Journal of China Pharmaceutical University, 2024, 55(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023112702
    [3]XU Shuyi, LI Yaxian, HU Hai, ZHANG Li, BIAN Yanlin, ZHU Jianwei, WU Mingyuan. Purification and activity of anti-PD-L1&CXCR4 bispecific nanobody[J]. Journal of China Pharmaceutical University, 2021, 52(5): 622-629. DOI: 10.11665/j.issn.1000-5048.20210516
    [4]CHEN Hongmei, KANG Yanliang, LIU Li, YAO Wenbing, TIAN Hong. Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets[J]. Journal of China Pharmaceutical University, 2020, 51(3): 349-356. DOI: 10.11665/j.issn.1000-5048.20200313
    [5]WAN Nanyan, JIANG Cuihua, GAO Meng, ZHANG Jian, YIN Zhiqi, PAN Ke. Paeoniflorin inhibits programmed cell death-1-ligand 1 expression in HepG2 cells by regulating JAK/STAT3 signal pathway[J]. Journal of China Pharmaceutical University, 2019, 50(2): 213-221. DOI: 10.11665/j.issn.1000-5048.20190213
    [6]TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101
    [7]PAN Jiajia, JIA Xiaoqing, HUANG Gang, ZHANG Yubin. PD-1/PD-Ls signaling pathway and the application of anti-PD-1/PD-Ls antibodies in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(1): 9-18. DOI: 10.11665/j.issn.1000-5048.20160102
    [8]LI Xinran, LIU Rui, LIU Fangkun, LIU Yu. Culture process for fully human anti-VEGF165 monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20150617
    [9]MIAO You-pan, LI Ai-xiu, LIU Tao, WU Ke-zhu. Molecular designing strategies of anti-drug-resistant HIV-1 protease inhibitors[J]. Journal of China Pharmaceutical University, 2009, 40(3): 279-283.
    [10]Kong Lingyi, Li Yi, Min Zhida. Study on Analysis of Pd Ia in Peucedanum Praerupto rum and Pd C I in Peucedanum Decursivum by RP HPLC[J]. Journal of China Pharmaceutical University, 1996, (4).

Catalog

    Article views (893) PDF downloads (792) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return